SA Multi-Managed International Equity Portfolio OCSE:NOVO B Holdings History
SA Multi-Managed International Equity Portfolio's Novo Nordisk AS Holding Summary
As of 2025-03-31, SEASONS SERIES TRUST held 42,499.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr2.95 Mil. This investment constitutes 1.21% of their stock portfolio, and SEASONS SERIES TRUST now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q3. And since then SA Multi-Managed International Equity Portfolio has made 6 purchases of OCSE:NOVO B, at an average price of kr309.39, for a total of 96,380.00 shares. In addition, there have been 15 sales at an average price of kr448.95 for 53,881.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, SA Multi-Managed International Equity Portfolio's estimated gain on his OCSE:NOVO B holdings is kr11.99 Mil, reflecting a 40.21% gain to date.
SA Multi-Managed International Equity Portfolio OCSE:NOVO B (kr414.60) Holding Chart
SA Multi-Managed International Equity Portfolio OCSE:NOVO B (kr414.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
